Meiners Torsten, Stechmann Bahne, Frank Ronald
Leibniz-Institut fuer Molekulare Pharmakologie (FMP), Robert-Roessle-Strasse 10, Berlin, 13125 Germany ; Helmholtz-Centre for Infection Research (HZI), Inhoffenstrasse 7, Braunschweig, 38124 Germany.
Leibniz-Institut fuer Molekulare Pharmakologie (FMP), Robert-Roessle-Strasse 10, Berlin, 13125 Germany.
J Chem Biol. 2014 Jul 31;7(4):113-8. doi: 10.1007/s12154-014-0118-9. eCollection 2014 Oct.
EU-OPENSCREEN is an academic research infrastructure initiative in Europe for enabling researchers in all life sciences to take advantage of chemical biology approaches to their projects. In a collaborative effort of national networks in 16 European countries, EU-OPENSCREEN will develop novel chemical compounds with external users to address questions in, among other fields, systems and network biology (directed and selective perturbation of signalling pathways), structural biology (compound-target interactions at atomic resolution), pharmacology (early drug discovery and toxicology) and plant biology (response of wild or crop plants to environmental and agricultural substances). EU-OPENSCREEN supports all stages of a tool development project, including assay adaptation, high-throughput screening and chemical optimisation of the 'hit' compounds. All tool compounds and data will be made available to the scientific community. EU-OPENSCREEN integrates high-capacity screening platforms throughout Europe, which share a rationally selected compound collection comprising up to 300,000 (commercial and proprietary compounds collected from European chemists). By testing systematically this chemical collection in hundreds of assays originating from very different biological themes, the screening process generates enormous amounts of information about the biological activities of the substances and thereby steadily enriches our understanding of how and where they act.
欧盟开放筛选计划是欧洲一项学术研究基础设施倡议,旨在使所有生命科学领域的研究人员能够在其项目中利用化学生物学方法。通过欧洲16个国家的国家网络共同努力,欧盟开放筛选计划将与外部用户合作开发新型化合物,以解决系统与网络生物学(信号通路的定向和选择性扰动)、结构生物学(原子分辨率下的化合物-靶点相互作用)、药理学(早期药物发现和毒理学)以及植物生物学(野生或作物对环境和农业物质的反应)等领域的问题。欧盟开放筛选计划支持工具开发项目的各个阶段,包括检测方法适配、高通量筛选以及“命中”化合物的化学优化。所有工具化合物和数据将向科学界公开。欧盟开放筛选计划整合了欧洲各地的高容量筛选平台,这些平台共享一个经过合理挑选的化合物库,其中包含多达30万种化合物(从欧洲化学家处收集的商业和专利化合物)。通过在数百种源自截然不同生物学主题的检测方法中系统地测试这个化学库,筛选过程产生了大量有关这些物质生物活性的信息,从而不断丰富我们对它们作用方式和作用部位的理解。